SCHEMBL17272739

SCHEMBL17272739

O=C(NCCC1CCN(CC2COc3ccccc3O2)CC1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17272737 1.00
SCHEMBL15865464 0.93 ADRA2A (0.57)
SCHEMBL15865463 0.93 ADRA2A (0.57)
SCHEMBL15864825 0.92 ADRA2A (0.61)
SCHEMBL15864823 0.92 ADRA2A (0.61)
SCHEMBL15865299 0.88
SCHEMBL15865300 0.88
SCHEMBL15865277 0.78
SCHEMBL15865276 0.78
SCHEMBL1927647 0.76 CHRM4 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2941427-B1 NOVEL BENZODIOXANE-PIPERIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS PF MEDICAMENT (FR) 2016-11-09 EP disclosed
US-20150336943-A1 NOVEL BENZODIOXANE-PIPERIDINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS FOR TREATING NEUROPSYCHIATRIC DISORDERS PIERRE FABRE MEDICAMENT (FR) 2015-11-26 US disclosed